Lena E. Friberg

Colistin alone versus colistin plus meropenem for treatment of severe infections caused by carbapenem-resistant Gram-negative bacteria: an open-label, randomised controlled trial

Mical Paul, George L. Daikos, Emanuele Durante‐Mangoni et al. · The Lancet Infectious Diseases · 2018 · 624 citations

Life Sciences, Infectious Diseases, Microbiology +14

Model of Chemotherapy-Induced Myelosuppression With Parameter Consistency Across Drugs

Lena E. Friberg, Anja Henningsson, Hugo Maas et al. · Journal of Clinical Oncology · 2002 · 528 citations

Medicine, Oncology, Pharmacology +17

Population Pharmacokinetic Analysis of Colistin Methanesulfonate and Colistin after Intravenous Administration in Critically Ill Patients with Infections Caused by Gram-Negative Bacteria

Diamantis Plachouras, Matti Karvanen, Lena E. Friberg et al. · Antimicrobial Agents and Chemotherapy · 2009 · 489 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +11

Pharmacokinetic/Pharmacodynamic (PK/PD) Indices of Antibiotics Predicted by a Semimechanistic PKPD Model: a Step toward Model-Based Dose Optimization

Elisabet I. Nielsen, Otto Cars, Lena E. Friberg · Antimicrobial Agents and Chemotherapy · 2011 · 249 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +17

Application of a Loading Dose of Colistin Methanesulfonate in Critically Ill Patients: Population Pharmacokinetics, Protein Binding, and Prediction of Bacterial Kill

Ami Fazlin Syed Mohamed, Ilias Karaiskos, Diamantis Plachouras et al. · Antimicrobial Agents and Chemotherapy · 2012 · 228 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +16